retatrutide mechanism gip glp-1 glucagon triple agonist Reta clinical trial data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, Retatrutide: The Next Generation of
Pay in 4 interest-free payments of $6.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27



























![Charizard (100/97) [EX: Dragon] XY20](https://cdn.shopify.com/s/files/1/0266/9513/9533/products/b8ac5f37-98df-4aa7-93a5-30db1ad1d7cf.png?v=1696327221)
